| Lcmc Er Physician Group | |
|
1902 S Us Highway 59 Parsons KS 67357-4948 | |
| (620) 421-4880 | |
| (620) 421-9544 |
| Full Name | Lcmc Er Physician Group |
|---|---|
| Speciality | Family Medicine |
| Location | 1902 S Us Highway 59, Parsons, Kansas |
| Authorized Official Name and Position | Thomas L Macaronas (CFO) |
| Authorized Official Contact | 6208205251 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Lcmc Er Physician Group 1902 S Us Highway 59 Parsons KS 67357-4948 Ph: (620) 421-4880 | Lcmc Er Physician Group 1902 S Us Highway 59 Parsons KS 67357-4948 Ph: (620) 421-4880 |
| NPI Number | 1336133362 |
|---|---|
| Provider Enumeration Date | 09/06/2005 |
| Last Update Date | 12/27/2007 |
| Medicare PECOS PAC ID | 5496664369 |
|---|---|
| Medicare Enrollment ID | O20031112000344 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336133362 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Mary C Swearengin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1093781270 PECOS PAC ID: 3072412048 Enrollment ID: I20040115000687 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Kelly Gordon |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1063495711 PECOS PAC ID: 6305748989 Enrollment ID: I20040123000572 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Brian J Fleeman |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1508814013 PECOS PAC ID: 4385547991 Enrollment ID: I20040130000533 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Timothy C Spears |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1639173156 PECOS PAC ID: 5597673327 Enrollment ID: I20040220000487 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Andrea K Willhite |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1801893748 PECOS PAC ID: 3375431943 Enrollment ID: I20040305000629 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Dennis G Higginbotham |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1669492658 PECOS PAC ID: 9133019888 Enrollment ID: I20040317000866 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Sonya K Culver |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1164423950 PECOS PAC ID: 1052397528 Enrollment ID: I20040625000350 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Verdon W Parham |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1437251964 PECOS PAC ID: 2062490865 Enrollment ID: I20040708001336 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Kolette L Smith |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1730187386 PECOS PAC ID: 4284614371 Enrollment ID: I20040721000016 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Jimmy V Buller |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1386641223 PECOS PAC ID: 4880641992 Enrollment ID: I20050331000986 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Albert J Giambrone |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1194790956 PECOS PAC ID: 2769429356 Enrollment ID: I20050414000975 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Richard L Price |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1609832013 PECOS PAC ID: 5597703561 Enrollment ID: I20050420000636 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | David M Beard |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1053376079 PECOS PAC ID: 7113918566 Enrollment ID: I20050607000876 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Jeffrey T Macmillan |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1295758365 PECOS PAC ID: 2466488945 Enrollment ID: I20050715000573 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Michael E Bolt |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1518943901 PECOS PAC ID: 3577509769 Enrollment ID: I20060116000353 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Osama M Ismael |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1841241551 PECOS PAC ID: 9436166188 Enrollment ID: I20060321000510 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | David L Black |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1235133679 PECOS PAC ID: 4789696626 Enrollment ID: I20060615000087 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Frank B Parks |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1922093731 PECOS PAC ID: 1153219332 Enrollment ID: I20060725000202 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Julia L Jensen |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1164469276 PECOS PAC ID: 9638063738 Enrollment ID: I20060814000450 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Shawn W Southwick |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1245278894 PECOS PAC ID: 8426027665 Enrollment ID: I20060824000269 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Neil A Goodloe |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1376589317 PECOS PAC ID: 6305840794 Enrollment ID: I20060825000301 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | John E Hetlinger |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1457373524 PECOS PAC ID: 8325042237 Enrollment ID: I20060907000475 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Justin R Reading |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1194733394 PECOS PAC ID: 9234136284 Enrollment ID: I20061103000465 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Dean A Heideman |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1790868677 PECOS PAC ID: 9335140102 Enrollment ID: I20070122000247 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Sonia Slaba |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1598815474 PECOS PAC ID: 0042212151 Enrollment ID: I20070202000123 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Bryan O Baxley |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1902934870 PECOS PAC ID: 1456454073 Enrollment ID: I20070319000571 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Roger B Moss |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1285698662 PECOS PAC ID: 3072611896 Enrollment ID: I20070601000365 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Sylvia L Orozco Do |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1386865202 PECOS PAC ID: 9739280116 Enrollment ID: I20070730000431 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | William John Nicholas |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1356387484 PECOS PAC ID: 7810085503 Enrollment ID: I20080404000691 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Tiffany K Main |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750327706 PECOS PAC ID: 8325127806 Enrollment ID: I20080508000708 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Chelsea Vargas |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790962843 PECOS PAC ID: 8729167127 Enrollment ID: I20080510000112 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Deborah D Byers |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1306879846 PECOS PAC ID: 4486604972 Enrollment ID: I20080805000466 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Ryan W Livermore |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1538381074 PECOS PAC ID: 9830264993 Enrollment ID: I20080825000294 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Patricia A Miller |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1497786024 PECOS PAC ID: 0840366902 Enrollment ID: I20080915000151 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Nathan C Buerge |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1184603391 PECOS PAC ID: 1355367798 Enrollment ID: I20081017000673 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Melinda R Allen Cullins |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1417014440 PECOS PAC ID: 2163582685 Enrollment ID: I20081113000472 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Cindi A Major |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1902006018 PECOS PAC ID: 5991868713 Enrollment ID: I20090106000049 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Thomas Payne |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1881849222 PECOS PAC ID: 5496812752 Enrollment ID: I20090401000090 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Jerry C Bouman |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1376518217 PECOS PAC ID: 3476571662 Enrollment ID: I20090504000026 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Scott B Fox |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1396977815 PECOS PAC ID: 6608912035 Enrollment ID: I20091015000077 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Anne Marie Gordon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1285866681 PECOS PAC ID: 5698815264 Enrollment ID: I20091214000233 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Joshua T Luce |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1437489036 PECOS PAC ID: 4284777632 Enrollment ID: I20100206000240 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Charlene M Mcdonald |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1821228743 PECOS PAC ID: 1254474315 Enrollment ID: I20100211000525 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Melissa J Mcintosh |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1366465817 PECOS PAC ID: 4486782950 Enrollment ID: I20100505000203 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Scott D Coates |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1689652877 PECOS PAC ID: 6709966344 Enrollment ID: I20100512001082 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Terrence Coffey |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1356571343 PECOS PAC ID: 4688708969 Enrollment ID: I20100823000749 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Dawn A Mccaffery |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568556074 PECOS PAC ID: 5698967081 Enrollment ID: I20101004000800 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Stephanie M Wagner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1689989501 PECOS PAC ID: 4880886969 Enrollment ID: I20101007000630 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Amber D Walker |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174832042 PECOS PAC ID: 5890988919 Enrollment ID: I20101021001014 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Stephanie A Adee |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1114235611 PECOS PAC ID: 4183813769 Enrollment ID: I20110113000087 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Tamara L Simon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457509895 PECOS PAC ID: 3274718770 Enrollment ID: I20110427000378 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Philip L Gorman |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1649475856 PECOS PAC ID: 2163691692 Enrollment ID: I20110817000723 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Charles C Gossman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164703153 PECOS PAC ID: 6103098389 Enrollment ID: I20111012000266 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Jillina Frazell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1578825006 PECOS PAC ID: 4284884958 Enrollment ID: I20121016000343 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Valerie K Weaver |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1770845331 PECOS PAC ID: 5395992556 Enrollment ID: I20121017000563 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Walter Joseph Turkowski |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1396749727 PECOS PAC ID: 4183722150 Enrollment ID: I20121022000213 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Donald E Beissel |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1952370207 PECOS PAC ID: 0749257053 Enrollment ID: I20121121000128 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Scott M Mcclintick |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1295933984 PECOS PAC ID: 5799818274 Enrollment ID: I20130103000111 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Pegah V Harlan |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1821239922 PECOS PAC ID: 3971780941 Enrollment ID: I20130219000210 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Mandy Thompson |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1245673045 PECOS PAC ID: 4981846631 Enrollment ID: I20130809000269 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | John Rexwinkle |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1699951129 PECOS PAC ID: 7618047994 Enrollment ID: I20130820000389 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Justin Fowler |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1386835585 PECOS PAC ID: 3971746058 Enrollment ID: I20130821000971 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Phillip D Shepard |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1356784581 PECOS PAC ID: 1254574841 Enrollment ID: I20130829000610 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Anne D Hogsett |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1699093583 PECOS PAC ID: 2264689280 Enrollment ID: I20130909000623 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Benjamin J Cochran |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1912339672 PECOS PAC ID: 7618102682 Enrollment ID: I20131029000052 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Stephanie M Thompson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1033559125 PECOS PAC ID: 0749418051 Enrollment ID: I20140113001642 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Amy Jo Smith |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1356773816 PECOS PAC ID: 7911136221 Enrollment ID: I20140207001699 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Corey M Padilla |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1649691072 PECOS PAC ID: 2961633730 Enrollment ID: I20140321000841 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Trevor Lynn Bond |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1811212202 PECOS PAC ID: 4082867346 Enrollment ID: I20140529001341 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Brook H Roberts |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1629375977 PECOS PAC ID: 7113100561 Enrollment ID: I20140623000707 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Delane H Vaughn |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1871888248 PECOS PAC ID: 2567610207 Enrollment ID: I20140716002298 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Kevin M Deao |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1891107652 PECOS PAC ID: 7810113453 Enrollment ID: I20140717000502 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Jonathan B Sperry |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1689081143 PECOS PAC ID: 5597982132 Enrollment ID: I20140805003059 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Matt Bogle |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1912314386 PECOS PAC ID: 4981823291 Enrollment ID: I20140919000060 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Paras Pravin Shah |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1043590292 PECOS PAC ID: 3173743267 Enrollment ID: I20141014000738 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Matthew D Bihlmaier |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1619276979 PECOS PAC ID: 1658685664 Enrollment ID: I20150805006540 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Christopher W Peer |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1669402137 PECOS PAC ID: 2567465990 Enrollment ID: I20150812008000 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Jennifer Bihlmaier |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1083964522 PECOS PAC ID: 7618284001 Enrollment ID: I20150917000874 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Chelsea J Bradfield |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1578939955 PECOS PAC ID: 1052612710 Enrollment ID: I20151222001850 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Robert B Legler |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1811128598 PECOS PAC ID: 8224253125 Enrollment ID: I20160111000464 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | David Wayne Brooks |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1790861052 PECOS PAC ID: 5991749665 Enrollment ID: I20160113002526 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Ma-ko Chen |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1134433303 PECOS PAC ID: 3072747393 Enrollment ID: I20160201000055 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Tammy Bushong |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1255791182 PECOS PAC ID: 2466750682 Enrollment ID: I20160420002138 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Shaun Mceuen |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1568825891 PECOS PAC ID: 0446559686 Enrollment ID: I20160422000528 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Darin Eugene Hamlin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669821047 PECOS PAC ID: 3173814340 Enrollment ID: I20160617000870 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Brett M Bruna |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1053742759 PECOS PAC ID: 0042441081 Enrollment ID: I20160701001438 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Holly Tyler Paris Pilson |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1891957478 PECOS PAC ID: 0840430195 Enrollment ID: I20160715000811 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Kristin R Collins |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1881045029 PECOS PAC ID: 7315230604 Enrollment ID: I20160725001260 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Caitlyn N Nguyen |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1760825855 PECOS PAC ID: 6901108455 Enrollment ID: I20160729001309 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Craig W Chandler |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1750318747 PECOS PAC ID: 6204813355 Enrollment ID: I20160818000642 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Ryan W Roberts |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1710436977 PECOS PAC ID: 6002103264 Enrollment ID: I20161003001239 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Jeffery L Knisley |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1609325158 PECOS PAC ID: 5991093932 Enrollment ID: I20161007000333 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Jessica B Coppock |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1568906246 PECOS PAC ID: 3779866280 Enrollment ID: I20170208000119 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Jenna King |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1588108187 PECOS PAC ID: 2668756644 Enrollment ID: I20170313001063 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Rachel Oreck |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1215293584 PECOS PAC ID: 2365752151 Enrollment ID: I20170523000701 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Shawn Zimbrunes |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1699119396 PECOS PAC ID: 6709154768 Enrollment ID: I20170615000171 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Bryce S Scott |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1720508237 PECOS PAC ID: 7315216629 Enrollment ID: I20170629002405 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Jeromy R Scofield |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1700336393 PECOS PAC ID: 6800175779 Enrollment ID: I20170630000709 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Joseph B Weimholt |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1093241135 PECOS PAC ID: 0042581795 Enrollment ID: I20170731000424 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Jessica L Rush |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1851622849 PECOS PAC ID: 5092846444 Enrollment ID: I20170906003265 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Aaditya Verma |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1396188439 PECOS PAC ID: 4981920147 Enrollment ID: I20170912002841 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Kiana D Long |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1285807362 PECOS PAC ID: 5496884397 Enrollment ID: I20171013000965 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Scott D Kaul |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1700390309 PECOS PAC ID: 6204195670 Enrollment ID: I20180109003543 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Robert Duane Strang |
|---|---|
| Provider Type | Practitioner - Neurosurgery |
| Provider Identifiers | NPI Number: 1013962935 PECOS PAC ID: 4880645043 Enrollment ID: I20180125000299 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Andrea N Dryden |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225319072 PECOS PAC ID: 9234303918 Enrollment ID: I20180126000124 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | John M Carlson |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1740640291 PECOS PAC ID: 4486928868 Enrollment ID: I20180213000347 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Logan T Wineland |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1316237399 PECOS PAC ID: 9537313911 Enrollment ID: I20180316001139 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Jeffrey Sadowsky |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1275517336 PECOS PAC ID: 9638100035 Enrollment ID: I20180612001117 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Andrew R Freedman |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1598766743 PECOS PAC ID: 7911990460 Enrollment ID: I20180630000133 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Anthony S Sado |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1548229925 PECOS PAC ID: 8729132873 Enrollment ID: I20180705002113 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Michael Allen Kirkover |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1366892986 PECOS PAC ID: 2365735263 Enrollment ID: I20180817001686 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Charles Cory Hallacy |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1295211704 PECOS PAC ID: 8224388632 Enrollment ID: I20180905003892 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Samantha Joellen Myers |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1528575545 PECOS PAC ID: 8224383518 Enrollment ID: I20180912002479 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Bradley K Demeritt |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1851873442 PECOS PAC ID: 8123371283 Enrollment ID: I20181019001300 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | John C Newcomer |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1295217248 PECOS PAC ID: 1456604073 Enrollment ID: I20181030000535 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Robin A Wilson |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1477029650 PECOS PAC ID: 2860745007 Enrollment ID: I20181105002895 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | William Arroyo |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1053608216 PECOS PAC ID: 7618262650 Enrollment ID: I20181222000201 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Christine C Tardif |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1437133428 PECOS PAC ID: 2466581400 Enrollment ID: I20181227000869 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Rafe Coker |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1437699915 PECOS PAC ID: 1557606258 Enrollment ID: I20190228000907 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Edward David Arrington |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1003889213 PECOS PAC ID: 0749529998 Enrollment ID: I20190305002763 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Lori Diane Isle |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568929172 PECOS PAC ID: 1052652302 Enrollment ID: I20190415000676 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Elizabeth Joann Marshall |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1437608163 PECOS PAC ID: 0547548885 Enrollment ID: I20190513001973 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Tercya Vanessa Ferreira Jarman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750854931 PECOS PAC ID: 4789917394 Enrollment ID: I20190613003020 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Morgan Gilkerson |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1669036075 PECOS PAC ID: 8921332933 Enrollment ID: I20190814002101 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Grant T Pierson |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1699034900 PECOS PAC ID: 0446572903 Enrollment ID: I20190816002809 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Briana Mykal Laforge |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1891352902 PECOS PAC ID: 0547598252 Enrollment ID: I20190820000189 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Casandra J Grimmett |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1710490016 PECOS PAC ID: 1355671140 Enrollment ID: I20190920001051 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Yash Patel |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1205284601 PECOS PAC ID: 0547591612 Enrollment ID: I20191004000824 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Aaron M Morgenstein |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1346537107 PECOS PAC ID: 7911134408 Enrollment ID: I20191125001335 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Neil G Bryan |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1932526035 PECOS PAC ID: 9638471519 Enrollment ID: I20191211001214 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Anthony Kouri |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1215355862 PECOS PAC ID: 6901100890 Enrollment ID: I20191231001793 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Robert Foster |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1932190972 PECOS PAC ID: 7911993837 Enrollment ID: I20200116001572 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Katherine Anderson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1023487436 PECOS PAC ID: 1355641523 Enrollment ID: I20200305000735 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Benjamin Smith |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1962063362 PECOS PAC ID: 6901233857 Enrollment ID: I20200305001517 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Jennifer B Allen |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1649619602 PECOS PAC ID: 9537302054 Enrollment ID: I20200511001463 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Brandon Lee Morris |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1215373196 PECOS PAC ID: 8224334909 Enrollment ID: I20200722003643 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Ryan G Bures |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1154973634 PECOS PAC ID: 0244567279 Enrollment ID: I20200728000712 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Eric S Hunn |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1740660687 PECOS PAC ID: 5496069536 Enrollment ID: I20200827000466 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Colin B Lisenby |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1679922652 PECOS PAC ID: 8628361524 Enrollment ID: I20201008003351 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Stacey Kale |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336510312 PECOS PAC ID: 5496059321 Enrollment ID: I20201021000588 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Franklin E Mayhue |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1669428421 PECOS PAC ID: 2668530882 Enrollment ID: I20210111001413 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Jason S Bruce |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1740218866 PECOS PAC ID: 2264402866 Enrollment ID: I20210121000135 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Harry S Calvino |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1497742142 PECOS PAC ID: 5799729661 Enrollment ID: I20210415002478 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Morris S Glover |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1447416862 PECOS PAC ID: 6608933080 Enrollment ID: I20210421000193 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | William T Rockwell |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1154881217 PECOS PAC ID: 3173942018 Enrollment ID: I20210504002753 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Tara Jacquelin Claussen |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1013240118 PECOS PAC ID: 2769633429 Enrollment ID: I20210512001748 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Zachary Degner |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1972035491 PECOS PAC ID: 8527330174 Enrollment ID: I20210611000653 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Patricia D Kiersey |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1629588827 PECOS PAC ID: 4082980933 Enrollment ID: I20210611000730 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Levi D Duethman |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1821550161 PECOS PAC ID: 2769801158 Enrollment ID: I20210616000758 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Kayla R. Daniels |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1649774605 PECOS PAC ID: 9032548839 Enrollment ID: I20210616001801 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Stephen Kelly |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1558504258 PECOS PAC ID: 7113185117 Enrollment ID: I20210629000252 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Jeremy Welwarth |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1841587649 PECOS PAC ID: 4385967751 Enrollment ID: I20210811002743 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | David S Smith |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1154363232 PECOS PAC ID: 8022074293 Enrollment ID: I20211027000159 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Logan Kendall Wedel |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1790289502 PECOS PAC ID: 8921342619 Enrollment ID: I20211201000364 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Mark D Brecheisen |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1740503416 PECOS PAC ID: 4082730544 Enrollment ID: I20211228001696 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Roberto Antonio Moran-bojorquez |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1063689651 PECOS PAC ID: 5597811893 Enrollment ID: I20220120001469 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Jennifer L Metscher |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477953479 PECOS PAC ID: 6002035201 Enrollment ID: I20220411002459 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Charles Alan Featherly |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1194762542 PECOS PAC ID: 2466418678 Enrollment ID: I20220415000557 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Eric Acosta |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1730702176 PECOS PAC ID: 6406276179 Enrollment ID: I20220427000591 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Brian Andrew Tessaro |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1043693724 PECOS PAC ID: 9638416654 Enrollment ID: I20220503002668 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Gretchen Lynn Garland |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1073075180 PECOS PAC ID: 7113307000 Enrollment ID: I20220709000171 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Elaina H Murray |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1487115143 PECOS PAC ID: 2062747348 Enrollment ID: I20221005001185 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Shelbie Cosby |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1245849967 PECOS PAC ID: 3779959580 Enrollment ID: I20221019002494 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Mallory Revell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1578172250 PECOS PAC ID: 7719353465 Enrollment ID: I20221020000999 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Ashley Holt |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1043940307 PECOS PAC ID: 2264815224 Enrollment ID: I20221130000220 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Skylar P Stacy |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1588289425 PECOS PAC ID: 3678991072 Enrollment ID: I20230911002015 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Victor M Tackett |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1518472281 PECOS PAC ID: 2163782178 Enrollment ID: I20231006002262 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
| Provider Name | Adele Bohn |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1831678473 PECOS PAC ID: 0749631513 Enrollment ID: I20240105000752 |
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
News Archive
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
Rochester Medical Corporation today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to $15,427,000 for the second quarter of last year. The Company also reported net income of $1,199,000 or $0.10 per diluted share compared to $603,000 or $0.05 per diluted share for the same period last year.
Although ultrasound is one of the most frequently prescribed treatments for one of the most common sport and athletic injuries – skeletal muscle contusions – there's really no good scientific evidence showing that it treats injured muscles effectively, said Steven Devor, the study's lead author and an assistant professor of sport and exercise sciences at Ohio State University.
› Verified 3 days ago
Parsons Community Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1708 Corning Ave, Parsons, KS 67357 Phone: 620-333-6080 Fax: 620-717-7322 | |
Labette Health Cherryvale Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1902 S Hwy 59, Parsons, KS 67357 Phone: 620-421-4880 Fax: 620-820-5274 | |
Rose Medical Clinic Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1509 Main St, Parsons, KS 67357 Phone: 620-421-0808 Fax: 620-421-0810 | |
Labette County Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1902 S Us Highway 59, Parsons, KS 67357 Phone: 620-421-4880 Fax: 620-421-9544 | |
Haskell Regional Hospital, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2323 Main St, Parsons, KS 67357 Phone: 888-339-7339 | |
Stover Chiropractic Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2328 Main St, Parsons, KS 67357 Phone: 620-717-4144 |